BRENT JACOBUS: Open Payments
NPI 1902807589 · CROWN POINT, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,323 in 69 payments from 22 companies in 2025. Trend: 2023 $1,985 · 2024 $1,355 · 2025 $1,323
Food & beverage: $1,308Education: $15
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $334 |
| Axsome Therapeutics, Inc. | 5 | $151 |
| PFIZER INC. | 6 | $106 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Corium, LLC | 3 | $68 |
| Almatica Pharma LLC | 3 | $68 |
| Vanda Pharmaceuticals Inc. | 2 | $63 |
| AstraZeneca Pharmaceuticals LP | 4 | $60 |
| Novo Nordisk Inc | 3 | $60 |
| Indivior Inc. | 2 | $45 |
Products named: VRAYLAR, Auvelity, REXULTI, NURTEC ODT, UBRELVY, Azstarys, LOREEV XR, FANAPT.
Industry payments across IN — which companies pay providers there.
